Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Eisai Gives Full Aduhelm Responsibility To Biogen Under Amended Agreement
Japanese Pharma Trades 50-50 Deal For Single-Digit Royalty
Mar 15 2022
•
By
Mandy Jackson
Eisai passed full Aduhelm decision-making authority to Biogen • Source: Alamy
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Deals
More from Business